Craft

EastGate Biotech

Stock Price

$0

2024-10-28

Market Capitalization

$9.3 M

2024-10-28

Revenue

$132 K

FY, 2015

EastGate Biotech Summary

Company Summary

Overview
EastGate Biotech produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body. EastGate Biotech develops products in which the active components are incorporated into vehicles containing nano-sized delivery vectors, including: oil droplets (nanoemulsions), polymeric particles (nanoparticles), and the combination of polymers and lipids with surfactants (hybrid nanoparticles, nanocapsules, mixed micelles). 
Type
Public
Status
Active
Founded
1999
HQ
Toronto, CA | view all locations
Website
http://www.eastgatebiotech.com/
Cybersecurity rating
Sectors

Key People

  • Anna Gluskin

    Anna Gluskin, CEO

    • Rose Perri

      Rose Perri, President

      LocationsView all

      1 location detected

      • Toronto, Ontario HQ

        Canada

      EastGate Biotech Financials

      Summary Financials

      Revenue (Q3, 2017)
      $23.1K
      Gross profit (Q3, 2017)
      ($69.2K)
      Net income (Q3, 2017)
      ($1.6M)
      Cash (Q3, 2017)
      $4.9K
      EBIT (Q3, 2017)
      ($1.7M)
      Enterprise value
      $9.9M

      Footer menu